Alethio Therapeutics raises $90M to target rare blood cancers
The startup is developing a medicine its investors say could reach more patients than approved drugs for myeloproliferative neoplasms.
Read at Biopharmadive โFull coverage ยท 4 outlets
- Biopharmadive ยท lead
- BioPharma DiveAlethio raises $90M to target rare blood cancers
- Yahoo FinanceAlethio Therapeutics Raises $90 Million (ยฃ67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
- BiopharmadiveAlethio raises $90M to target rare blood cancers